Ondine Biomedical Inc. (AIM:OBI)
London · Delayed Price · Currency is GBP · Price in GBX 11.00
+0.25 (2.33%)
Mar 25, 2026, 4:34 PM GMT
Ondine Biomedical Market Cap
Ondine Biomedical has a market cap or net worth of 55.85 million as of March 25, 2026. Its market cap has increased by 36.09% in one year.
Market Cap
55.85M
Enterprise Value
53.17M
Revenue
1.18M
Ranking
n/a
PE Ratio
n/a
Stock Price
11.00
Market Cap Chart
Since December 6, 2021, Ondine Biomedical's market cap has decreased from 112.86M to 55.85M, a decrease of -50.51%. That is a compound annual growth rate of -15.09%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 25, 2026 | 55.85M | 43.69% |
| Dec 31, 2025 | 38.87M | 9.33% |
| Dec 31, 2024 | 35.55M | 79.20% |
| Dec 29, 2023 | 19.84M | -50.26% |
| Dec 30, 2022 | 39.89M | -63.06% |
| Dec 31, 2021 | 107.99M | -4.31% |
| Dec 6, 2021 | 112.86M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Scancell Holdings | 116.75M |
| 4basebio | 73.98M |
| Bioventix | 73.15M |
| Hemogenyx Pharmaceuticals | 61.43M |
| Faron Pharmaceuticals Oy | 49.79M |
| hVIVO | 45.58M |
| Poolbeg Pharma | 29.09M |
| Arecor Therapeutics | 25.11M |